Search
Search Results
##search.searchResults.foundPlural##
-
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3316PDF: 967HTML: 3147 -
SOLITARY PLASMACYTOMA
4189PDF: 2242HTML: 1401fIGURES 1,2: 252 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1947PDF: 1042HTML: 246 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2562HTML: 305PDF: 942 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3525PDF: 821HTML: 3022Figure 1a and 1b: 171Figure 2: 179Figure 3: 198Figure 4: 178Figure 5: 183Tables 1-5: 167 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3858PDF: 1647HTML: 859Figures . Eliassian: 253 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4619PDF: 1785HTML: 1223 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2287PDF: 1838HTML: 838 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3719PDF: 2600HTML: 1625 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2594PDF: 1744HTML: 534 -
MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman
3496PDF: 1652HTML: 679 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
574PDF: 280HTML: 121 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3339PDF: 1064HTML: 2403 -
Persistent Fever and Splenic Abscess-like Lesions: A Diagnostic Trap in a Young Adult
40PDF: 32Suppl. Files: 6Html: 9Html Suppl. Files: 4 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4058PDF: 1097HTML: 3897Untitled: 187Cneo. Fig.1: 125Untitled: 120Untitled: 145Untitled: 154 -
-
Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone, De novo polycythemia vera following AML remission
1791PDF: 828HTML: 301 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2281PDF: 1667HTML: 563 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3793PDF: 935HTML: 6875 -
FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
4609PDF: 1686HTML: 4286Tables and Images: 258 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1162PDF: 1216Suppl. Files: 586HTML: 98 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
3003PDF: 1410HTML: 3723Untitled: 216Untitled: 227Untitled: 200 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2615PDF: 878HTML: 9057Efremov 1: 254Efremov 2: 216 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1480PDF: 961HTML: 253 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1851PDF: 909HTML: 1473
1 - 47 of 47 items







